The 11 upstream regulators predicted by IPA control the expression of Nr4a2, Slc6a1 and Igf1r, genes that are also involved in AD progression, neuroinflammation pathways and synaptic LTD (Figure 11A and Figure 14). This evidence concerns the gene SLC6A1 and Alzheimer disease.